reports
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the ...
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia ANN ARBOR, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) and Otsuka Pharmaceutical Co., Ltd (Otsuka) announced today that the primary endpoint was achieved in the Phase 3 trial in Japan for bempedoic acid as a potential treatment for patients with hypercholesterolemia. The trial demonstrated statistically significant outcomes on the primary endpoint for bempedoic acid and highlighted its potential future value to patients in Japan. Bempedoic acid, created by Esperion...
Fractyl Health Presents Compelling Preclinical Data from Single-Admini...
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024 Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% (p
MediciNova Receives Notice of Allowance for New Patent Covering MN-166...
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer LA JOLLA, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (ibudilast) for the prevention of metastasis of eye cancer. Once issued, this patent is exp...
ICON plc to hold Investor Day Meeting on May 30, 2024
DUBLIN--(BUSINESS WIRE)-- , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will hold an Investor Day which will take place on Thursday, May 30, 2024 in New York City, starting at 10am ET. The event will include presentations from members of ICON’s executive team, and access to a live webcast will be made available in on the Investor section of our website. It is expected that the presentations, followed by a question and answer session, will conclude at approximately 1pm ET. Any changes to these events and links to the live ...
Tomy Co: 1 director
A director at Tomy Co sold 1,000,000 shares at 2,711.500JPY and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Tigerelec Co Ltd: 1 director
A director at Tigerelec Co Ltd sold 260,203 shares at 38,800.000KRW and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
TBC Bank Group: 2 directors
Two Directors at TBC Bank Group bought 17,606 shares at between 2,633p and 2,722p. The significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Roxas & Company Inc: 2 directors
Two Directors at Roxas & Company Inc bought 49,482,697 shares at 2.000PHP. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
- Julie Boote
- Nia Dokova
- Pelham Smithers
- William Nestuk
PSA Today 20 May: Bonds fall as commodity prices rise / Camera market ...
PSA Today Japan Market Comment by Pelham Smithers, Julie Boote, William Nestuk and Nia Dokova Tags: Sumitomo Metal Mining (5713 JT), Mitsubishi Materials (5711 JT), Shin-Etsu Chemical (4063 JT), SoftBank Group (9984 JT), ARM Holdings (ARM US), Disco (6146 JT), Advantest (6857 JT), Socionext (6526 JT), Sony (6758 JT), Apollo (pvt), Paramount Global (PARA US), Square Enix (9684 JT), Nintendo (7974 JT), Konami (9766 JT), Bandai Namco (7832 JT), Nexon (3659 JT), Microsoft (MSFT US), Canon (7751 JT)...
Net Asset Value(s)
Net Asset Value(s) WisdomTree Issuer plc – Daily Fund Prices 17-May-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc17/05/2024IE00BDVPNG1314054630USD887,958,099.8963.179WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged17/05/2024IE00BFNNN2361581717EUR132,248,394.7283.6107WisdomTree AT1 CoCo Bond UCITS ETF - GBP Hedged17/05/2024IE00BFNNN459165051GBP14,460,539.0987.6126WisdomTree AT1 CoCo Bond UCITS ETF - USD17/05/2024IE00BZ0XVF52677005USD57,142,676.0584.4051WisdomTree AT1 CoCo Bond UCITS ETF - USD Acc17/05/2024IE00BZ0XVG6950789USD5,882,115.90115.8148WisdomTree A...
BitFuFu Inc. Reports Unaudited First Quarter 2024 Financial Results
BitFuFu Inc. Reports Unaudited First Quarter 2024 Financial Results SINGAPORE, May 20, 2024 (GLOBE NEWSWIRE) -- BitFuFu Inc., (“BitFuFu” or “the Company”) (NASDAQ: FUFU), a fast-growing digital asset mining service and world-leading cloud-mining service provider, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Operational Highlights Hosting capacity of 644 MW diversified across 29 sites on three continents, compared with 513 MW across 22 sites on one continent during the same period of 2023Total mining capacity under manage...
B.F. Holding S.p.A: 1 director
A director at B.F. Holding S.p.A bought 19,198 shares at 3.801EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Aryzta AG: 1 director
A director at Aryzta AG bought 10,000 shares at 1.755CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Optima bank S.A.: 1 director
A director at Optima bank S.A. sold 25,500 shares at 11.494EUR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
MCAN Financial Group: 1 director
A director at MCAN Financial Group sold 33,215 shares at 15.710CAD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
VEON’s Banglalink and Robi Axiata Partner to Explore Network Sharing t...
VEON’s Banglalink and Robi Axiata Partner to Explore Network Sharing to Expand 4G Access in Bangladesh Amsterdam and Dhaka, 20 May 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that Banglalink, its digital operator in Bangladesh, has signed a Memorandum of Understanding (MoU) with Robi, second largest mobile operator in the Bangladesh and a subsidiary of Axiata Group, to explore potential sharing and optimization of network resources, aiming to expand 4G coverage and enhance network per...
- Franc Gregori
- Lala Gregorek
- Philippa Gardner
Arecor Therapeutics: AT278 ultra-concentrated insulin superior to benc...
Arecor’s lead compound AT278, a unique ultra-rapid and ultra-concentrated insulin, has successfully shown superiority to benchmark fast-acting or concentrated insulins in a Phase I study in Type II diabetes (T2D). This follows a similarly positive outcome in a previous Phase I study in Type I diabetics (T1D). Demonstrating AT278’s clinical efficacy in difficult-to-treat overweight/obese T2D patients confirms the validity of the formulation, shows its profile is attractive for T2D patients with h...
- Marilou SIANO
- Nathalie Dezeure
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.